Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Mount Sinai Beth Israel, New York, New York Mount Sinai - West, New York, New York Dubin breast Center, New York, New York